Page last updated: 2024-09-04

2'-hydroxyflavone and 2'-hydroxyflavanone

2'-hydroxyflavone has been researched along with 2'-hydroxyflavanone in 1 studies

Compound Research Comparison

Studies
(2'-hydroxyflavone)
Trials
(2'-hydroxyflavone)
Recent Studies (post-2010)
(2'-hydroxyflavone)
Studies
(2'-hydroxyflavanone)
Trials
(2'-hydroxyflavanone)
Recent Studies (post-2010) (2'-hydroxyflavanone)
100441032

Protein Interaction Comparison

ProteinTaxonomy2'-hydroxyflavone (IC50)2'-hydroxyflavanone (IC50)
Androgen receptorHomo sapiens (human)3.7
Corticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)10
Aldo-keto reductase family 1 member C3Homo sapiens (human)0.2333

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goto, M; Izumi, K; Mizokami, A; Nakagawa-Goto, K; Saito, Y; Tsurimoto, H1

Other Studies

1 other study(ies) available for 2'-hydroxyflavone and 2'-hydroxyflavanone

ArticleYear
5'-Chloro-2,2'-dihydroxychalcone and related flavanoids as treatments for prostate cancer.
    European journal of medicinal chemistry, 2018, Sep-05, Volume: 157

    Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcones; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavonoids; Humans; Male; Mice; Mice, SCID; Molecular Structure; Neoplasms, Experimental; Prostatic Neoplasms; Receptors, Androgen; Structure-Activity Relationship

2018